What is Radiaction?
Radiaction Medical is a specialized developer of advanced radiation protection solutions, engineered to address the persistent health risks associated with ionizing radiation in clinical settings. The company's core innovation, the Radiaction Smart Shield, functions as a dynamic barrier that effectively blocks scatter radiation at the source. Unlike traditional, cumbersome lead-based protective gear, this technology is designed to integrate seamlessly into existing interventional workflows, thereby enhancing procedural efficiency without compromising the safety of physicians and support staff.
By prioritizing the health of medical professionals, Radiaction is effectively increasing the procedural capacity of hospitals and clinics. Their solutions are increasingly recognized for their clinical utility, providing a scalable answer to the occupational hazards inherent in modern interventional medicine. The company's market position is bolstered by its commitment to evidence-based design and its ability to solve complex operational challenges in the operating room.
How much funding has Radiaction raised?
Radiaction has raised a total of $30.6M across 2 funding rounds:
Unspecified
$18M
Series C
$12.6M
Unspecified (2020): $18M with participation from InnovaHealth Partners LP
Series C (2023): $12.6M led by InnovaHealth Partners
Key Investors in Radiaction
InnovaHealth Partners
InnovaHealth Partners is a New York City-based investment firm specializing in growth buyouts of established medical technology companies. The firm focuses on high-growth sectors of the medical device industry, partnering with management teams to develop innovative technologies that address significant unmet surgical needs.
InnovaHealth Partners LP
An affiliate of the primary investment firm, focusing on strategic capital deployment within the medical device and healthcare technology sectors.
Undisclosed Strategic Investor
An undisclosed investor participating in the funding round, providing essential capital to support the scaling of radiation protection technology.
What's next for Radiaction?
With the recent influx of capital, Radiaction is well-positioned to accelerate its commercial expansion and deepen its penetration into the global medical device market. The strategic focus will likely shift toward scaling manufacturing capabilities and expanding the clinical adoption of the Smart Shield platform. As the company moves beyond its current growth stage, it will likely prioritize further clinical validation studies and the development of next-generation protective barriers to address evolving needs in interventional radiology and cardiology.
The firm's ability to attract high-caliber investment suggests a clear path toward long-term sustainability and potential market leadership. Future initiatives will likely involve strengthening strategic partnerships with major healthcare systems and medical device distributors, ensuring that their protective technology becomes a standard component of the modern interventional suite.
